Cambridge, UK - 15th September 2016
Following completion of the Innovate UK funded collaboration between Nuformix and Vectura, the first patent resulting from the project has published. The patent covering novel forms of a proprietary Vectura molecule describes cocrystal forms discovered and developed by Nuformix during the project.
Nuformix Chief Executive Officer, Dr Dan Gooding, said: “I’m pleased to see this first patent from our collaboration with Vectura emerge and hope to announce more in the future. Vectura’s decision to file IP covering novel cocrystal drug forms further validates the value of the technology, alongside Nuformix’s ability to discover novel patentable drug forms.”